newsfilter
← Latest News
GlobeNewswire·

Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates

Received FDA Fast Track designation for stenoparib in advanced ovarian cancer Reported landmark median overall survival now exceeding 25 months in ongoing Phase 2 trialAdvanced DRP® platform through new